Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.81 | ||
| Change(%) | ![]() | 0.00 | |
| Volume | 418972 | ||
| 2:25 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon Reports Strong First Quarter 2009 Results
--Company continues to improve its capital structure--
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business --
Enzon's HIF-1 alpha Antagonist Shows Antitumor Activity
--Innovative and diverse pipeline advances--
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting

Enzon Stockholders Approve Company Proposals at 2009 Annual Meeting
Enzon Continues to Improve its Capital Structure
-- Company repurchased $17.5 million of its outstanding debt at a discount to par--
Jack Geltosky, Ph.D. Joins Enzon's Board of Directors
Enzon Pharmaceuticals to Add New Independent Director to Board
